Lv1
10 积分 2025-10-09 加入
Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond
3个月前
已完结
Targeting RAS in gastrointestinal malignancies
7个月前
已关闭
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens
9个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
9个月前
已完结
Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
9个月前
已完结
皖公网安备34019202002308
